Iulia Diaconu, PhD

 
IULIA_.jpg

Iulia Diaconu, PhD

Director of Immunotherapy

Iulia Diaconu PhD, is Director of Immunotherapy at ElevateBio since April 2019. She is responsible for leading ElevateBio’s translational immunotherapy programs and developing second generation product candidates. Iulia comes from Bluebird Bio 2014-2019 where she was Associate Director of Immunotherapy and was responsible for preclinical development of immunotherapy CAR/TCR T cell products for various Oncology indications. Iulia was formerly a post-doctoral fellow at Baylor College of Medicine/ Center for Cell and Gene therapy developing CAR T cell and virus specific T cell products for hematological cancers. She started her research career 17 years ago in the pathology department of Oncological Institute, Cluj-Napoca, Romania and she continued her training with a PhD in Pharmacology from University of Medicine and Pharmacy “Iuliu Hatieganu”, Romania studying prognostic and diagnostic markers for endometriosis and ovarian cancer.

Iulia also holds a PhD in Medicine from University of Helsinki, Finland, studying efficacy and safety of oncolytic virus therapies.